Skip to main content
Cancer Explained
Donate

NewsTrending topic

The FDA gains authority to regulate tobacco products

The FDA gains authority to regulate tobacco products (United States, 2009). What changed, who is affected, and what it does and doesn't mean.

By Cancer Explained Editorial TeamPublished Updated

Original commentary from the Cancer Explained editorial team.

A hand sets a lighter down on a wooden table beside a stoneware mug
Setting It Down — illustrative photograph, not of anyone named in this story.

Historical context: this page explains an event dated 2009. It was published as an explainer on July 12, 2026 and is not breaking news.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

A cancer law that never mentions a patient

On 22 June 2009 the Family Smoking Prevention and Tobacco Control Act became law as Public Law 111-31. It gave the Food and Drug Administration authority over how tobacco products are made, sold and advertised in the United States.

It is one of the largest cancer measures Congress has passed. It names no treatment, no screening test and no clinic. It works entirely upstream, on the product itself.

What the law puts in place

FDA's own summary lists the main provisions.

Sales to young people are restricted. The law bans most vending machine sales, packs of fewer than 20 cigarettes, tobacco-brand sponsorship of sports and cultural events, and free samples of cigarettes and branded merchandise.

Smokeless tobacco packages must carry one of four rotating warnings, covering at least 30% of each of the two main sides of the pack. On advertisements the warning must cover at least 20% of the space. The four warnings name mouth cancer, gum disease and tooth loss, addiction, and the fact that smokeless tobacco is not safer than cigarettes.

Companies cannot call a product "light," "low" or "mild" unless they file a modified risk tobacco product application and FDA issues an order allowing it.

Manufacturers must give FDA detailed ingredient information, register every year, and open their factories to inspection every two years.

Cigarettes with characterizing flavors are banned, with menthol and tobacco excepted. A user fee on manufacturers, set by market share, pays for the work.

What Congress kept off the table

FDA lists four things the agency cannot do under this law. It cannot require a prescription to buy tobacco. It cannot require nicotine to be reduced to zero. It cannot ban face-to-face sales in a category of retail outlet. And it cannot ban a whole class of tobacco product.

The minimum age is worth a footnote. The 2009 Act set it at 18. The federal minimum rose to 21 on 20 December 2019, when the President signed separate legislation amending the Federal Food, Drug, and Cosmetic Act. FDA says that change took effect immediately.

Why tobacco carries a cancer law at all

NCI puts the toll plainly. Cigarette smoking and exposure to tobacco smoke cause about 480,000 early deaths a year in the United States. About 36% of those are from cancer, 39% from heart disease and stroke, and 24% from lung disease.

Tobacco smoke carries more than 7,000 chemicals. At least 250 are known to be harmful, and at least 69 of those can cause cancer — among them benzene, formaldehyde, arsenic, cadmium and polonium-210.

The damage is not limited to the lungs. NCI links smoking to cancers of the lung, esophagus, larynx, mouth, throat, kidney, bladder, liver, pancreas, stomach, cervix, colon and rectum, and to acute myeloid leukemia.

For a person who smokes, NCI's clinical lung cancer summary puts the risk at roughly ten times that of a lifetime nonsmoker. Risk rises with the number of cigarettes, the years of smoking, and a younger starting age.

Nonsmokers are not outside this. NCI attributes about 7,300 lung cancer deaths a year in the United States to secondhand smoke, and reports that living with a smoker raises a nonsmoker's lung cancer risk by 20% to 30%.

What the disease looks like when it arrives

Lung cancer often announces itself late, and vaguely. NCI's clinical summary lists the most common symptoms at presentation: a cough that is getting worse, chest pain, coughing up blood, feeling generally unwell, weight loss, breathlessness and hoarseness.

Some symptoms come from a tumor pressing on something nearby: on the esophagus, causing trouble swallowing; on the nerves to the voice box, causing hoarseness; or on the superior vena cava, the large vein returning blood from the head, causing a swollen face and neck with visible veins.

SEER, the federal cancer surveillance program, shows the cost of finding it late. The roughly 229,410 new lung and bronchus cancer diagnoses and 124,990 deaths it lists for the United States in 2026 are American Cancer Society projections, and they are more deaths than any other cancer. Five-year relative survival is 65.5% when the cancer is still confined to the lung, 38.2% once it reaches nearby lymph nodes, and 10.5% once it has spread further. Fifty-one percent are already at that last stage when found.

Those are group figures from people diagnosed in past years. They describe a population, not a person. Our overview of lung cancer goes through the types and stages.

When to get checked

There is a screening test here, and it has a numeric threshold.

The U.S. Preventive Services Task Force recommends a yearly low-dose CT scan of the chest for adults aged 50 to 80 who have a 20 pack-year smoking history and who either still smoke or quit within the past 15 years. A pack-year is one pack a day for a year, so it is also half a pack a day for two years. Screening stops after 15 smoke-free years, or if another health problem would rule out lung surgery.

Separately from screening, any of the symptoms above lasting more than about three weeks is worth an appointment. Coughing up blood warrants one sooner. Cancer screening explains what a screening test is for, and the benefits and harms of screening covers the trade-offs, which are real.

What quitting buys

NCI is direct: whatever a person's age, quitting substantially lowers the risk of disease, including cancer, and reduces precancerous changes in the airway. It also states the limit. People who have quit keep a raised lung cancer risk for years, which is why the screening rule still includes those who stopped up to 15 years ago.

What this does and doesn't change

The Act regulates a product. It does not treat anyone, and no individual's care changed on 22 June 2009.

Its effects are slow by design. Lung cancer follows exposure by decades, so a law aimed at who starts smoking shows up in registry data a generation later.

Rules move. Menthol, flavored products and nicotine levels have all drawn later FDA action, so check FDA's site for the current rules where you live.

Sources

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Lung cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI